Hepatitis B infection in Minnesota: a case for universal immunization

Area of Science:

• Public Health
• Infectious Disease Prevention
• Vaccinology

Background:

• Hepatitis B virus (HBV) transmission poses a significant public health challenge.
• Previous selective vaccination strategies for high-risk groups proved insufficient in reducing HBV transmission.
• The Minnesota Department of Health initiated universal vaccination strategies in 1993.

Purpose of the Study:

• To evaluate the effectiveness of universal hepatitis B vaccination strategies in Minnesota.
• To assess the impact of universal screening of pregnant women and vaccination of infants and adolescents.

Main Methods:

• Universal screening of pregnant women for hepatitis B surface antigen (HBsAg).
• Universal vaccination of infants and adolescents.
• Surveillance of hepatitis B cases and vaccination coverage.

Main Results:

• 761 infants born to HBsAg-positive mothers were identified and received prophylaxis and vaccination.
• Vaccination coverage reached 78% for children aged 19-35 months.
• Hepatitis B incidence remained low, with fewer than 100 acute cases reported annually statewide since 1991.

Conclusions:

• Universal hepatitis B vaccination strategies are effective in reducing transmission.
• Successful implementation was demonstrated even in a generally low-risk population.
• Public health initiatives can significantly impact infectious disease control.